Sort   by:  
 Page size 
Unknown<sup>31</sup> P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations.
Not available
S-EPMC8243949 | biostudies-literature
UnknownSepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy.
Not available
S-EPMC4682118 | biostudies-literature
UnknownIncreased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.
Not available
S-EPMC7357297 | biostudies-literature
UnknownAssessment of disease progression in dysferlinopathy: A 1-year cohort study.
Not available
S-EPMC6369904 | biostudies-literature
UnknownImmunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Not available
S-EPMC10867612 | biostudies-literature
UnknownSarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
Not available
S-EPMC8598187 | biostudies-literature
UnknownRisk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Not available
S-EPMC7543792 | biostudies-literature
UnknownEffect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.
Not available
S-EPMC7825875 | biostudies-literature
UnknownEffect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Not available
S-EPMC7577198 | biostudies-literature
UnknownMuscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
Not available
S-EPMC6166612 | biostudies-literature
Sort   by:  
 Page size